Jack Hutter

Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

Melinda Hamer, Katherine V. Houser, Amelia R. Hofstetter et al. · The Lancet · 2023 · 65 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Trial Evaluating Ambulatory Therapy of Travelers’ Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide

Mark S. Riddle, Patrick Connor, Jamie Fraser et al. · Clinical Infectious Diseases · 2017 · 57 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults

James E. Moon, Christian F. Ockenhouse, Jason A. Regules et al. · The Journal of Infectious Diseases · 2020 · 47 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials

Alfredo J Mena Lora, Jessica E. Long, Yunda Huang et al. · JAMA Network Open · 2023 · 37 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adults

Jack Hutter, Paul M. Robben, Christine Lee et al. · Vaccine · 2022 · 25 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17